Annual Retained Earnings
-$194.35 M
-$4.83 M-2.55%
March 31, 2024
Summary
- As of February 7, 2025, SNOA annual retained earnings is -$194.35 million, with the most recent change of -$4.83 million (-2.55%) on March 31, 2024.
- During the last 3 years, SNOA annual retained earnings has fallen by -$15.07 million (-8.41%).
- SNOA annual retained earnings is now -617.68% below its all-time high of -$27.08 million, reached on March 31, 2005.
Performance
SNOA Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$197.03 M
-$928.00 K-0.47%
December 31, 2024
Summary
- As of February 7, 2025, SNOA quarterly retained earnings is -$197.03 million, with the most recent change of -$928.00 thousand (-0.47%) on December 31, 2024.
- Over the past year, SNOA quarterly retained earnings has dropped by -$3.75 million (-1.94%).
- SNOA quarterly retained earnings is now -627.58% below its all-time high of -$27.08 million, reached on March 31, 2005.
Performance
SNOA Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
SNOA Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.5% | -1.9% |
| 3 y3 years | -8.4% | -4.0% |
| 5 y5 years | -14.8% | -4.0% |
SNOA Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -8.4% | at low | -8.6% | at low |
| 5 y | 5-year | -14.8% | at low | -15.3% | at low |
| alltime | all time | -617.7% | at low | -627.6% | at low |
Sonoma Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | -$197.03 M(+0.5%) |
| Sep 2024 | - | -$196.10 M(+0.3%) |
| Jun 2024 | - | -$195.49 M(+0.6%) |
| Mar 2024 | -$194.35 M(+2.6%) | -$194.35 M(+0.6%) |
| Dec 2023 | - | -$193.28 M(+0.5%) |
| Sep 2023 | - | -$192.42 M(+0.8%) |
| Jun 2023 | - | -$190.93 M(+0.7%) |
| Mar 2023 | -$189.51 M(+2.8%) | -$189.51 M(+0.7%) |
| Dec 2022 | - | -$188.21 M(+1.0%) |
| Sep 2022 | - | -$186.27 M(+0.5%) |
| Jun 2022 | - | -$185.25 M(+0.5%) |
| Mar 2022 | -$184.36 M(+2.8%) | -$184.36 M(+1.6%) |
| Dec 2021 | - | -$181.42 M(+0.5%) |
| Sep 2021 | - | -$180.47 M(+0.1%) |
| Jun 2021 | - | -$180.38 M(+0.6%) |
| Mar 2021 | -$179.28 M(+2.3%) | -$179.28 M(+3.9%) |
| Dec 2020 | - | -$172.54 M(+0.4%) |
| Sep 2020 | - | -$171.89 M(+0.4%) |
| Jun 2020 | - | -$171.25 M(-2.3%) |
| Mar 2020 | -$175.33 M(+3.6%) | -$175.33 M(+2.6%) |
| Dec 2019 | - | -$170.87 M(+0.6%) |
| Sep 2019 | - | -$169.78 M(+0.7%) |
| Jun 2019 | - | -$168.58 M(-0.4%) |
| Mar 2019 | -$169.24 M(+7.5%) | -$169.24 M(+1.9%) |
| Dec 2018 | - | -$166.02 M(+1.4%) |
| Sep 2018 | - | -$163.72 M(+1.8%) |
| Jun 2018 | - | -$160.90 M(+2.2%) |
| Mar 2018 | -$157.44 M(+10.0%) | -$157.44 M(+3.1%) |
| Dec 2017 | - | -$152.68 M(+2.1%) |
| Sep 2017 | - | -$149.49 M(+2.0%) |
| Jun 2017 | - | -$146.62 M(+2.5%) |
| Mar 2017 | -$143.10 M(-6.1%) | -$143.10 M(+1.7%) |
| Dec 2016 | - | -$140.66 M(-10.3%) |
| Sep 2016 | - | -$156.89 M(+1.3%) |
| Jun 2016 | - | -$154.94 M(+1.7%) |
| Mar 2016 | -$152.38 M | -$152.38 M(+1.9%) |
| Dec 2015 | - | -$149.47 M(+2.2%) |
| Sep 2015 | - | -$146.32 M(+1.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | - | -$144.55 M(+1.6%) |
| Mar 2015 | -$142.21 M(+6.1%) | -$142.21 M(+1.1%) |
| Dec 2014 | - | -$140.71 M(+4.4%) |
| Sep 2014 | - | -$134.80 M(+0.5%) |
| Jun 2014 | - | -$134.08 M(+0.1%) |
| Mar 2014 | -$134.01 M(-2.7%) | -$134.01 M(-5.3%) |
| Dec 2013 | - | -$141.47 M(+0.4%) |
| Sep 2013 | - | -$140.86 M(+1.0%) |
| Jun 2013 | - | -$139.46 M(+1.2%) |
| Mar 2013 | -$137.75 M(+4.1%) | -$137.75 M(+1.8%) |
| Dec 2012 | - | -$135.30 M(+1.4%) |
| Sep 2012 | - | -$133.39 M(+1.2%) |
| Jun 2012 | - | -$131.87 M(-0.3%) |
| Mar 2012 | -$132.31 M(+5.9%) | -$132.31 M(+1.4%) |
| Dec 2011 | - | -$130.55 M(+2.0%) |
| Sep 2011 | - | -$128.00 M(+0.7%) |
| Jun 2011 | - | -$127.16 M(+1.7%) |
| Mar 2011 | -$124.98 M(+6.8%) | -$124.98 M(+1.4%) |
| Dec 2010 | - | -$123.29 M(+1.8%) |
| Sep 2010 | - | -$121.06 M(+1.4%) |
| Jun 2010 | - | -$119.41 M(+2.0%) |
| Mar 2010 | -$117.04 M(+7.9%) | -$117.04 M(+1.3%) |
| Dec 2009 | - | -$115.58 M(+1.2%) |
| Sep 2009 | - | -$114.24 M(+1.7%) |
| Jun 2009 | - | -$112.35 M(+3.6%) |
| Mar 2009 | -$108.48 M(+19.4%) | -$108.48 M(+2.1%) |
| Dec 2008 | - | -$106.26 M(+3.2%) |
| Sep 2008 | - | -$102.94 M(+7.2%) |
| Jun 2008 | - | -$96.03 M(+5.7%) |
| Mar 2008 | -$90.83 M(+28.9%) | -$90.83 M(+5.2%) |
| Dec 2007 | - | -$86.35 M(+6.5%) |
| Sep 2007 | - | -$81.05 M(+7.3%) |
| Jun 2007 | - | -$75.50 M(+7.1%) |
| Mar 2007 | -$70.49 M(+40.1%) | -$70.49 M(+9.9%) |
| Dec 2006 | - | -$64.16 M(+8.4%) |
| Sep 2006 | - | -$59.21 M(+17.7%) |
| Mar 2006 | -$50.30 M(+85.7%) | -$50.30 M(+85.7%) |
| Mar 2005 | -$27.08 M | -$27.08 M |
FAQ
- What is Sonoma Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Sonoma Pharmaceuticals?
- What is Sonoma Pharmaceuticals annual retained earnings year-on-year change?
- What is Sonoma Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Sonoma Pharmaceuticals?
- What is Sonoma Pharmaceuticals quarterly retained earnings year-on-year change?
What is Sonoma Pharmaceuticals annual retained earnings?
The current annual retained earnings of SNOA is -$194.35 M
What is the all time high annual retained earnings for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals all-time high annual retained earnings is -$27.08 M
What is Sonoma Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, SNOA annual retained earnings has changed by -$4.83 M (-2.55%)
What is Sonoma Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of SNOA is -$197.03 M
What is the all time high quarterly retained earnings for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals all-time high quarterly retained earnings is -$27.08 M
What is Sonoma Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, SNOA quarterly retained earnings has changed by -$3.75 M (-1.94%)